| Literature DB >> 15239631 |
Ragai R Mitry1, Anil Dhawan, Robin D Hughes, Sanjay Bansal, Sharon Lehec, Claire Terry, Nigel D Heaton, John B Karani, Giorgina Mieli-Vergani, Mohamed Rela.
Abstract
Hepatocyte transplantation is emerging as a possible treatment for patients with acute liver failure and liver-based metabolic disorders. With the limited availability of donor tissue, it is important to find new sources of liver tissue for isolation of high-quality hepatocytes. Segment IV with or without the caudate lobe was removed during three split-liver procedures. Hepatocytes were isolated from the tissues using a collagenase perfusion technique under strict sterile conditions. The mean number of hepatocytes that were isolated was 5.14 x 10(8) cells with a mean cell viability of 89%. Two of the hepatocyte preparations were used for cell transplantation in a 1-day-old boy with an antenatal diagnosis of a severe urea cycle defect caused by ornithine transcarbamylase deficiency. The six recipients of split-liver grafts demonstrated no complications related to the removal of segment IV. Segment IV with or without the caudate lobe obtained from split-liver procedures is potentially a good source of high-quality hepatocytes for cell transplantation.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15239631 DOI: 10.1097/01.tp.0000122224.98318.19
Source DB: PubMed Journal: Transplantation ISSN: 0041-1337 Impact factor: 4.939